- Home
- ASB vs CRNX Comparison
ASB vs CRNX Comparison
Compare ASB & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ASB | CRNX |
|---|---|---|
| Founded | 1861 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.1B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | ASB | CRNX |
|---|---|---|
| Price | $27.70 | $44.54 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 9 |
| Target Price | $28.82 | ★ $75.78 |
| AVG Volume (30 Days) | ★ 2.4M | 1.0M |
| Earning Date | 01-22-2026 | 02-26-2026 |
| Dividend Yield | ★ 3.39% | N/A |
| EPS Growth | ★ 284.72 | N/A |
| EPS | ★ 2.77 | N/A |
| Revenue | ★ $1,433,549,000.00 | $1,535,000.00 |
| Revenue This Year | $19.08 | $499.13 |
| Revenue Next Year | $7.73 | $893.14 |
| P/E Ratio | $10.21 | ★ N/A |
| Revenue Growth | ★ 50.45 | 47.74 |
| 52 Week Low | $18.32 | $24.10 |
| 52 Week High | $29.52 | $57.99 |
Technical Indicators
Market Signals| Indicator | ASB | CRNX |
|---|---|---|
| Relative Strength Index (RSI) | 51.71 | 35.47 |
| Support Level | $28.31 | $43.94 |
| Resistance Level | $29.49 | $48.58 |
| Average True Range (ATR) | 0.80 | 2.55 |
| MACD | 0.03 | -0.77 |
| Stochastic Oscillator | 44.69 | 5.85 |
Price Performance
Historical ComparisonAbout ASB Associated Banc-Corp
Associated Banc-Corp is a bank holding company. The company through its subsidiaries provides a broad array of banking and nonbanking products and services to individuals and businesses. The company operates in three reportable segments; Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty and Community, Consumer, and Business segments.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.